Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility Mapping.

TitleIron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility Mapping.
Publication TypeJournal Article
Year of Publication2016
AuthorsStüber C, Pitt D, Wang Y
JournalInt J Mol Sci
Volume17
Issue1
Date Published2016 Jan 14
ISSN1422-0067
KeywordsAnimals, Biomarkers, Brain, Humans, Iron, Magnetic Resonance Imaging, Multiple Sclerosis
Abstract

Iron is considered to play a key role in the development and progression of Multiple Sclerosis (MS). In particular, iron that accumulates in myeloid cells after the blood-brain barrier (BBB) seals may contribute to chronic inflammation, oxidative stress and eventually neurodegeneration. Magnetic resonance imaging (MRI) is a well-established tool for the non-invasive study of MS. In recent years, an advanced MRI method, quantitative susceptibility mapping (QSM), has made it possible to study brain iron through in vivo imaging. Moreover, immunohistochemical investigations have helped defining the lesional and cellular distribution of iron in MS brain tissue. Imaging studies in MS patients and of brain tissue combined with histological studies have provided important insights into the role of iron in inflammation and neurodegeneration in MS.

DOI10.3390/ijms17010100
Alternate JournalInt J Mol Sci
PubMed ID26784172
PubMed Central IDPMC4730342
Grant ListR01 EB013443 / EB / NIBIB NIH HHS / United States
R01 NS090464 / NS / NINDS NIH HHS / United States
NIH R01NS090464 / NS / NINDS NIH HHS / United States
R01EB013443 / EB / NIBIB NIH HHS / United States
Related Institute: 
MRI Research Institute (MRIRI)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065